Literature DB >> 28421682

Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study.

Rebecca McKetin1,2, Astrid Kothe3, Amanda L Baker4, Nicole K Lee1, Joanne Ross2, Dan I Lubman5.   

Abstract

INTRODUCTION AND AIMS: We previously found that residential rehabilitation increased continuous abstinence from methamphetamine use 1 year after treatment. We examine what client and treatment characteristics predict this outcome. DESIGN AND METHODS: Participants (n = 176) were dependent on methamphetamine and entering residential rehabilitation for methamphetamine use. Simultaneous logistic regression was used to identify independent predictors of continuous abstinence from methamphetamine use at 1 year follow-up. Measures included demographics, drug use, psychiatric comorbidity (Diagnostic and Statistical Manual of Mental Disorders, major depression, social phobia, panic disorder, schizophrenia, mania and conduct disorder), symptoms of psychosis and hostility, readiness to change, motivations for treatment and treatment characteristics (duration, rapport, group and individual counselling).
RESULTS: Participants stayed in treatment for a median of 8 weeks; 23% remained abstinent at 1 year. The only independent predictors of abstinence were more weeks in treatment [adjusted odds ratio (AOR) 1.2, P < 0.001], better rapport with treatment providers (AOR 2.4, P = 0.049) and receipt of individual counselling (AOR 3.7, P = 0.013), whereas injecting methamphetamine predicted not achieving abstinence (AOR = 0.25, P = 0.002). Individual counselling and good rapport increased abstinence to 45%; for injectors, longer stays in treatment (13+ weeks) were additionally needed to produce similar abstinence rates (43%). DISCUSSIONS AND
CONCLUSIONS: Abstinence from methamphetamine use following residential rehabilitation could be significantly increased by providing individual counselling, maintaining good rapport with clients and ensuring longer stays for people who inject the drug. [McKetin R, Kothe A, Baker AL, Lee NK, Ross J, Lubman DI. Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study. Drug Alcohol Rev 2018;37:70-78].
© 2017 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Keywords:  abstinence; methamphetamine; rehabilitation; substance use disorder; treatment

Mesh:

Substances:

Year:  2017        PMID: 28421682     DOI: 10.1111/dar.12528

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  7 in total

1.  Computational models of exploration and exploitation characterise onset and efficacy of treatment in methamphetamine use disorder.

Authors:  Alex H Robinson; Trevor T-J Chong; Antonio Verdejo-Garcia
Journal:  Addict Biol       Date:  2022-05       Impact factor: 4.093

2.  Altered patterns of fractional amplitude of low-frequency fluctuation and regional homogeneity in abstinent methamphetamine-dependent users.

Authors:  An Xie; Qiuxia Wu; Winson Fu Zun Yang; Chang Qi; Yanhui Liao; Xuyi Wang; Wei Hao; Yi-Yuan Tang; Jianbin Liu; Tieqiao Liu; Jinsong Tang
Journal:  Sci Rep       Date:  2021-04-08       Impact factor: 4.379

3.  Protocol for the methamphetamine approach-avoidance training (MAAT) trial, a randomised controlled trial of personalised approach bias modification for methamphetamine use disorder.

Authors:  Joshua B B Garfield; Hugh Piercy; Shalini Arunogiri; Dan I Lubman; Samuel C Campbell; Paul G Sanfilippo; Jeff Gavin; Malcolm Hopwood; Eli Kotler; Suzanne George; Goke Okedara; Lara R Piccoli; Victoria Manning
Journal:  Trials       Date:  2021-01-06       Impact factor: 2.279

4.  Associations between psychosocial risk factors, and changes in substance dependence and psychosocial functioning, during engagement with digital cognitive behavioral therapy for methamphetamine use: use of 'Breaking Free from Substance Abuse' by incarcerated people during the COVID-19 pandemic.

Authors:  Sarah Elison-Davies; Jamie Newsome; Andrew Jones; Glyn Davies; Jonathan Ward
Journal:  Health Justice       Date:  2022-09-07

5.  Biochemical Neuroadaptations in the Rat Striatal Dopaminergic System after Prolonged Exposure to Methamphetamine Self-Administration.

Authors:  Subramaniam Jayanthi; Bruce Ladenheim; Patricia Sullivan; Michael T McCoy; Irina N Krasnova; David S Goldstein; Jean Lud Cadet
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

Review 6.  Responding to global stimulant use: challenges and opportunities.

Authors:  Michael Farrell; Natasha K Martin; Emily Stockings; Annick Bórquez; Javier A Cepeda; Louisa Degenhardt; Robert Ali; Lucy Thi Tran; Jürgen Rehm; Marta Torrens; Steve Shoptaw; Rebecca McKetin
Journal:  Lancet       Date:  2019-10-23       Impact factor: 79.321

7.  Adults With Opioid and Methamphetamine Co-use Have Lower Odds of Completing Short-Term Residential Treatment Than Other Opioid Co-use Groups: A Retrospective Health Services Study.

Authors:  Orrin D Ware; Jennifer I Manuel; Andrew S Huhn
Journal:  Front Psychiatry       Date:  2021-12-08       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.